Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Merck and Eisai halt late-stage trial as Keytruda/Lenvima combo fails to improve survival in liver cancer. Read more here.

The Capitals’ captain has two goals in 12 games. The streaky scorer is confident that goals will come. The banners that track ...

Soon after returning to the White House, Mr. Trump issued a sweeping order to halt all leasing of federal lands and waters ...

A recent study from Oregon State University estimated that more than 3,500 animal species are at risk of extinction because ...

There's been a new top team in the ACC seemingly every week. The reign of undefeated success for Haynes King and the Georgia Tech Yellow Jackets has come to an unexpected end. This race is still ...

Learn how to pass the FE Exam with a smart study plan, focused practice, and exam-day strategies that lead to success.

West Ham face crucial test as Paqueta’s future uncertainty growsPressure mounts amid Paqueta speculationWest Ham United are ...

What makes athletes mentally tough? Research points to two coaching approaches that work side by side to build psychological ...

Educators have long reported struggles to keep up with the paperwork associated with IEPs. Now, they say AI platforms can ...

In a Physical Review Letters study, the HOLMES collaboration has achieved the most stringent upper bound on the effective ...